Ali Ajam MD
Associate Professor, Rheumatology, Division of Internal Medicine, Ohio State University College of Medicine
Join to View Full Profile
543 Taylor AveSte 3084Columbus, OH 43203
Phone+1 614-293-4837
Fax+1 614-293-3125
Dr. Ajam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Arkansas for Medical Sciences (UAMS) College of MedicineFellowship, Rheumatology, 2006 - 2008- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2003 - 2006
Dow University of Health SciencesClass of 2000
Certifications & Licensure
OH State Medical License 2009 - 2027
AR State Medical License 2005 - 2010
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
Publications & Presentations
PubMed
- 2 citationsFrom Skin to Solution: Exploring Epicutaneous Immunotherapy for Peanut Allergy-A Systematic Review and Meta-Analysis.Umm E Salma Shabbar Banatwala, Muhammad Moiz Nasir, Reema Javed, Areeba Ahmed, Syed Ali Farhan
Clinical Reviews in Allergy & Immunology. 2024-04-01 - 33 citationsSafety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trialLorinda Chung, Cathie Spino, Richard McLain, Sindhu R. Johnson, Christopher P. Denton
The Lancet. Rheumatology. 2020-12-01 - 166 citationsAbatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator‐Initiated, Multicenter, Double‐Blind, Randomized, Placebo‐Controlled TrialDinesh Khanna, Cathie Spino, Sindhu R. Johnson, Lorinda Chung, Michael L. Whitfield
Arthritis & Rheumatology. 2020-01-01
Press Mentions
How Does Scleroderma Affect the Esophagus? The Red Flags to Be Aware OfFebruary 28th, 2020- What Is Scleroderma Renal Crisis? The Key Symptoms You Need to Watch ForFebruary 26th, 2020
7 Tips for Practicing Yoga with ArthritisJanuary 6th, 2020
Other Languages
- German, Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
